ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror

During the COVID-19 pandemic, a correspondence, published at the Lancet Respiratory Medicine, that linked angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and ibuprofen to a higher risk of SARS CoV-2 infection and complications, has influenced, when adopted by official health...

Descripción completa

Detalles Bibliográficos
Autor principal: Kelleni, Mina T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486973/
https://www.ncbi.nlm.nih.gov/pubmed/32920716
http://dx.doi.org/10.1007/s10787-020-00755-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486973/
https://www.ncbi.nlm.nih.gov/pubmed/32920716
http://dx.doi.org/10.1007/s10787-020-00755-x

Ejemplares similares